Your browser doesn't support javascript.
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Cable, Jennifer; Fauci, Anthony; Dowling, William E; Günther, Stephan; Bente, Dennis A; Yadav, Pragya Dhruv; Madoff, Lawrence C; Wang, Lin-Fa; Arora, Rahul K; Van Kerkhove, Maria; Chu, May C; Jaenisch, Thomas; Epstein, Jonathan H; Frost, Simon David William; Bausch, Daniel G; Hensley, Lisa E; Bergeron, Éric; Sitaras, Ioannis; Gunn, Michael D; Geisbert, Thomas W; Muñoz-Fontela, César; Krammer, Florian; de Wit, Emmie; Nordenfelt, Pontus; Saphire, Erica Ollmann; Gilbert, Sarah C; Corbett, Kizzmekia S; Branco, Luis M; Baize, Sylvain; van Doremalen, Neeltje; Krieger, Marco A; Clemens, Sue Ann Costa; Hesselink, Renske; Hartman, Dan.
  • Cable J; PhD Science Writer, New York, New York, USA.
  • Fauci A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
  • Günther S; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany.
  • Bente DA; University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, USA.
  • Yadav PD; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
  • Madoff LC; Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Wang LF; Department of Medicine, University of Massachusetts Chan School of Medicine, Worcester, Massachusetts, USA.
  • Arora RK; Duke-NUS Medical School, Singapore.
  • Van Kerkhove M; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Chu MC; Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Jaenisch T; World Health Organization, Geneva, Switzerland.
  • Epstein JH; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Frost SDW; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Bausch DG; EcoHealth Alliance, New York, New York, USA.
  • Hensley LE; Microsoft Research, Redmond, Washington, USA.
  • Bergeron É; FIND, the global alliance for diagnostics, Geneva, Switzerland.
  • Sitaras I; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Gunn MD; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Geisbert TW; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Muñoz-Fontela C; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Krammer F; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • de Wit E; University of Manitoba, Winnipeg, Manitoba, Canada.
  • Nordenfelt P; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Saphire EO; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany.
  • Gilbert SC; Department of Microbiology and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Corbett KS; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
  • Branco LM; Department of Clinical Sciences Lund, Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
  • Baize S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • van Doremalen N; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Krieger MA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Clemens SAC; Zalgen Labs, Germantown, Maryland, USA.
  • Hesselink R; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France.
  • Hartman D; Centre International de Recherche en Infectiologie (CIRI), Lyon, France.
Ann N Y Acad Sci ; 2022 Oct 02.
Article in English | MEDLINE | ID: covidwho-2052884
ABSTRACT
The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements-notably, in low-to-middle income countries-must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research / Randomized controlled trials Language: English Year: 2022 Document Type: Article Affiliation country: Nyas.14898

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research / Randomized controlled trials Language: English Year: 2022 Document Type: Article Affiliation country: Nyas.14898